-The Hindu ‘Healthcare as an optional public service’ would ensure the legal right to receive free, quality care in a public institution The lingering COVID-19 crisis is a good time to revive an issue that is, oddly, slow to come to life in India — universal health care (UHC). Meanwhile, UHC has become a well-accepted objective of public policy around the world. It has even been largely realised in many countries, not...

On Janaushadhi Diwas this year (i.e., March 7th, 2022), Prime Minister Shri Narendra Modi stated that the poor and the middle-class benefited from the 'Jan Aushadhi Kendras' that were set up to provide generic drugs at affordable prices. He said that the poor and the middle class saved around Rs.13,000 crore through these stores during the COVID-19 pandemic. In the wake of COVID 19 crisis, the 'Bureau of Pharma PSUs of India'...

-Down to Earth People in low-, middle-income countries often have to pay out of their pocket and seek care elsewhere Funding in primary healthcare systems in low- and middle-income countries is insufficient and access to it inequitable, a new study has reiterated. Patients often have to pay for the services out of their pocket, the report published in the journal The Lancet Global Health April 4, 2022 noted, adding that these systems have...

-The New Indian Express A significant share, almost two-thirds of OOP expenses, are for purchasing outpatient care, especially medicines. NEW DELHI: Household Out-Of-Pocket (OOP) expenses on health services, especially medicines, continue to push over 55 million people in India into poverty, with over 18 per cent of households incurring catastrophic levels of health expenditures annually, says a WHO report. Despite India’s billing as the ‘pharmacy of the world,’ its population’s access to medicines...

-Down to Earth Tough new conditions emerge in the compromise deal to ease WTO intellectual property barriers to production of COVID-19 medical tools We are back to square one. Back to the beginning after 18 months of a wearying, tortuous series of negotiations that carried on while millions of lives hung in the balance — and still do. The waiver of intellectual property (IP) rights on medicines, vaccines and diagnostics to fight the...